Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2007 / Cilt: 41 - Sayı: 2

Expression of cell proliferation markers in benign, premalignant and malignant lesions and human papillomavirus isolation

Benin, premalin ve malin lezyonlarda hücre proliferasyon belirleyicilerinin ekspresyonu ve insan papilloma virus izolasyonu

Pages
57–62
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the lesions, the Ki-67, p21 and bcl-2 expressions were found to be increased respectively: KA

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: This study was designed to investigate the role of proliferation markers in various benign, premalignant and malignant skin lesions and also aimed to detect HPV positivity in these lesions.
📊
Key Findings & Data:MATERIAL-METHOD: A total of 62 paraffin blocks [12 seborrheic keratoses (SK), 10 keratoacantoma (KA), 8 actinic keratoses (AK), 22 basal cell carcinoma (BCC), and 10 squamous cell carcinoma (SCC)] were included in the study.
💡
Conclusion & Impact:In the lesions, the Ki-67, p21 and bcl-2 expressions were found to be increased respectively: KA
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: This study was designed to investigate the role of proliferation markers in various benign, premalignant and malignant skin lesions and also aimed to detect HPV positivity in these lesions. MATERIAL-METHOD: A total of 62 paraffin blocks [12 seborrheic keratoses (SK), 10 keratoacantoma (KA), 8 actinic keratoses (AK), 22 basal cell carcinoma (BCC), and 10 squamous cell carcinoma (SCC)] were included in the study. Specimens were studied immunohistochemically for the expression of Ki-67, p21 and bcl-2. PCR was performed to detect HPV DNA. RESULTS: HPV positivity was detected in two tissues of BCC (HPV type-16). In the lesions, the Ki-67, p21 and bcl-2 expressions were found to be increased respectively: KA

Özet

AMAÇ: Bu çalışmada çeşitli benin, premalin ve malin deri lezyonlarında proliferasyon belirleyicilerinin rolü ve bu lezyonlarda insan papilloma virusu (HPV) pozitifliğinin saptanması amaçlandı. GEREÇ-YÖNTEM: Çalışmaya, parafin bloktaki 62 doku [12 seboreik keratoz (SK), 10 keratoakantom (KA), 8 aktinik keratoz (AK), 22 bazal hücreli karsinom (BHK) ve 10 skuamöz hücreli karsinom (SHK)] alındı. Doku örnekleri, Ki-67, p21 ve bcl-2 ekspresyonunu belirlemek amacıyla, immünohistokimyasal yöntemle çalışıldı. HPV DNA’sını tespit etmek için PCR uygulandı. BULGULAR: BHK tanısı almış olan iki dokuda HPV (tip-16) pozitifliği saptandı. Lezyonlarda Ki-67, p21 ve bcl-2 ekspresyonu sırası ile şu şekildeydi: KA

🔖

Cite This Article

DURMAZ, R., SERARSLAN, G., BAKARİŞ, S., OTLU, B., ATİK, E. (2022). Expression of cell proliferation markers in benign, premalignant and malignant lesions and human papillomavirus isolation. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 41 - Sayı: 2, 57–62. https://ajindex.com/articles/622154

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Lu S, Tiekso J, Hietanen S, Syrjanen K, Havu VK, Syrjanen S: Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement. Acta Derm Venereol 1999;79:268-73
  2. Wrone-Smith T, Bergstrom J, Quevedo ME, Reddy V, Gutierrez- Steil C, Nikoloff BJ: Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions. J Dermatol Sci 1999;19:53-67
  3. Murphy M, Mabruk MJEMF, Lenane P, Liew A, McCann P, Buckley A, Flatharta CO, Hevey D, Bilet P, Robertson W, Javed S, Leader M, Kay E, Murphy GM: Comparison of the expression of p53, p21, Bax and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation. J Clin Pathol 2002;55:829-33
  4. Berhane T, Halliday GM, Cooke B, Barnestson RSC: Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol 2002;146:810-5
  5. Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, Wojnarowska F, Breuer J, McGregor JM: Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004;150:949-57
  6. Termorshuizen F, Feltkamp MCW, Struijk L, Gruijl FR, Bavinck JNB, Loveren H: Sunlight exposure and (sero)prevalence of epidermadysplasia verruciformis-associated human papillomavirus. J Invest Dermatol 2004;122:1456-62
  7. De Villiers EM: Taxonomic classification of papillomaviruses. Papillomavirus Report 2001;12:57-63
  8. Forslund O, Reid C, Higgins G: A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003;149:64-73
  9. Iftner A, Klug SJ, Garbe C, Blum A, Stancu A, Wilczynski SP, Iftner T: The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunsuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 2003;63:7515-9
  10. Meyer T, Arndt R, Christophers E, Nindi I, Stockfleth E: Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev 2001;25:533-47
  11. Li Y-H, Chen G, Dong X-P, Chen H-D: Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis. Br J Dermatol 2004;151:1060-5
  12. Tieben LM, Berkhout RJ, Smi